Search results
Dr Richard Finn is a professor of Medicine at the Geffen School of Medicine at UCLA in the Department of Medicine, Division of Hematology/Oncology.
Sep 25, 2021 · Dr. Richard Finn, of UCLA’s Jonsson Comprehensive Cancer Center, is the lead researcher into a new type of liver cancer treatment that was recently approved by the FDA.
View in: PubMed Mentions: Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2023 06 03; 401 (10391):1853-1865.
May 13, 2020 · “The therapy is a real game-changer for people diagnosed with this aggressive disease,” said the study’s principal investigator and lead author, Dr. Richard Finn, a professor of medicine at the David Geffen School of Medicine at UCLA and director of the signal transduction and therapeutics program at the UCLA Jonsson ...
Dr. Finn, Professor of Clinical Medicine, Department of Medicine, Division of Hematology/ Oncology, Geffen School of Medicine, UCLA, considers the role of sy...
Richard Finn, MD, is professor of medicine at the David Geffen School of Medicine at UCLA, and director of the Jonsson Comprehensive Cancer Center Signal Transduction & Therapeutics Program.
Richard S. Finn, MD, professor of clinical medicine, Department of Medicine, Division of Hematology/Oncology, Geffen School of Medicine, University of California, Los Angeles (UCLA), and...
Richard Finn, MD. Professor, Department of Medicine, Hematology/Oncology. Physician, Department of Surgery, Dumont-UCLA Liver Cancer Center. Director, Signal Transduction and Therapeutics. Languages. English. Specialty. Hematology, Internal Medicine, Medical Oncology. View provider profile. Education. Fellowship.
Richard Finn, MD associate professor of Medicine at the UCLA David Geffen School of Medicine, discusses what’s next for palbociclib following the PALOMA trials.
Sep 10, 2018 · Dr Richard Finn is an Assistant Professor of Medicine at the Geffen School of Medicine at UCLA in the Department of Medicine, Division of Hematology/ Oncology.
